(E)-ETHYL 3-(2-CYANOPHENYL)ACRYLATE, 95.0%, 500mg

6-(tert-Butyl) 2-methyl 7,8-dihydro-1,6-naphthyridine-2,6(5H)-dicarboxylate, 97%, 5g

Methyl 5-chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylate, 98%, 1g

5-AMINOPYRIMIDINE-2-CARBONITRILE, 95.0%, 100mg

Fase de planificación PLPHi 20x/0,40 objetivo IOS corregido al infinito. Distancia de trabajo 8,80 mm

2,4-Dimethoxybenzylamine, 98.0%, 1g

4-(Methylsulfonyl)-2-nitrophenol, 95.0%, 10g

Methyl 2-fluoro-5-hydroxyisonicotinate, 98%, 250mg

Ethyl 3-isocyanatopropionate, 95.0%, 1g

9-(4'-Bromo-4-biphenylyl)-9H-carbazole, 97.0%, 25g

1-tert-Butyl 2-methyl (2S)-2-methylpyrrolidine-1,2-dicarboxylate, 95%, 1g

3-Aminophenylacetic acid methyl ester, 95.0%, 1g

ZERUMBONE, 95%, 100mg